Vitality Watch

Dossier pubmed observational 08-jun-2026
Human cohort, case-control, or epidemiological association

Associations of sleep duration and insomnia with cardiometabolic disease onset, multimorbidity, and mortality: A prospective study in 461,046 Chinese adults.

Key claim: In 461,046 Chinese adults followed ~10 years, abnormal sleep duration (<7 or >9 h) and insomnia were each independently associated with higher risks of first cardiometabolic disease, cardiometabolic multimorbidity, and all-cause mortality, with highest risks when both were present.

Abstract

AIMS: To investigate the independent and joint associations of sleep duration and insomnia with the incidence of first cardiometabolic disease (FCMD), cardiometabolic multimorbidity (CMM), and all-cause mortality among Chinese adults. METHODS: We conducted a prospective cohort study among 461,046 adults at baseline from the China Kadoorie Biobank. Participants were followed for incident FCMD, CMM (defined as the occurrence of two or more CMDs), and all-cause mortality. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the independent and joint associations of sleep duration and insomnia with each outcome. RESULTS: Over a median follow-up of approximately 10 years, 73,159 participants (15.9%) developed FCMD, 12,183 (2.6%) developed CMM, and 33,259 (7.2%) died. Compared with normal sleep duration (7-9 h/day), abnormal sleep duration (<7 or >9 h/day) was associated with higher risks of FCMD (HR = 1.04, 95% CI: 1.02-1.06), CMM (HR = 1.10, 95% CI: 1.05-1.14), and all-cause mortality (HR = 1.07, 95% CI: 1.04-1.09). Insomnia was similarly associated with higher risks of FCMD (HR = 1.08, 95% CI: 1.06-1.11), CMM (HR = 1.10, 95% CI: 1.05-1.16), and all-cause mortality (HR = 1.07, 95% CI: 1.04-1.11). Joint analyses showed a graded pattern, with the highest risks consistently observed among participants with both abnormal sleep duration and insomnia. Associations were broadly consistent across population subgroups. CONCLUSION: Abnormal sleep duration and insomnia were independently and jointly associated with higher incidence risks of FCMD, CMM, and all-cause mortality.

Why this matters

In 461,046 Chinese adults followed ~10 years, abnormal sleep duration (<7 or >9 h) and insomnia were each independently associated with higher risks of first cardiometabolic disease, cardiometabolic multimorbidity, and all-cause mortality, with highest risks when both were present.

Source

Link

Briefing card

Associations of sleep duration and insomnia with cardiometabolic disease onset, multimorbidity, and mortality: A prospective study in 461,046 Chinese adults.
Stage: observational · pubmed · 08-jun-2026

In 461,046 Chinese adults followed ~10 years, abnormal sleep duration (<7 or >9 h) and insomnia were each independently associated with higher risks of first cardiometabolic disease, cardiometabolic multimorbidity, and all-cause mortality, with highest risks when both were present.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.sleep.2026.109073

build build 880 · 2bcef25 · 2026-11-18